Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/168451
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
Autor: | Álvarez-Twose, Iván; Jara-Acevedo, Maria; Morgado, J. M.; García-Montero, Andrés CSIC ORCID; Sánchez-Muñoz, Laura; Teodosio, Cristina; Matito, Almudena; Mayado, Andrea; Caldas, Carolina; Mollejo, Manuela; Orfao, Alberto CSIC ORCID ; Escribano, Luis | Palabras clave: | Imatinib KIT Mast cell Mastocytosis Well differentiated |
Fecha de publicación: | 2016 | Editor: | Elsevier | Citación: | Journal of Allergy and Clinical Immunology 137(1): 168-178.e1 (2016) | Resumen: | [Background]: Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. [Objective]: We sought to determine the clinical, biological, and molecular features of a cohort of 33 patients with mastocytosis in the skin in association with BM infiltration by well-differentiated MCs and to establish potential diagnostic criteria for WDSM. Methods Thirty-three patients with mastocytosis in the skin plus BM aggregates of round, fully granulated MCs lacking strong CD25 and CD2 expression in association with clonal MC features were studied. [Results]: Our cohort of patients showed female predominance (female/male ratio, 4:1) and childhood onset of the disease (91%) with frequent familial aggregation (39%). Skin involvement was heterogeneous, including maculopapular (82%), nodular (6%), and diffuse cutaneous (12%) mastocytosis. KIT mutations were detected in only 10 (30%) of 33 patients, including the KIT D816V (n = 5), K509I (n = 3), N819Y (n = 1), and I817V (n = 1) mutations. BM MCs displayed a unique immunophenotypic pattern consisting of increased light scatter features, overexpression of cytoplasmic carboxypeptidase, and aberrant expression of CD30, together with absent (79%) or low (21%) positivity for CD25, CD2, or both. Despite only 9 (27%) of 33 patients fulfilling the World Health Organization criteria for SM, our findings allowed us to establish the systemic nature of the disease, which fit with the definition of WDSM. [Conclusions]: WDSM represents a rare clinically and molecularly heterogeneous variant of SM that requires unique diagnostic criteria to avoid a misdiagnosis of cutaneous mastocytosis per current World Health Organization criteria. | URI: | http://hdl.handle.net/10261/168451 | DOI: | 10.1016/j.jaci.2015.05.008 | Identificadores: | doi: 10.1016/j.jaci.2015.05.008 e-issn: 1097-6825 issn: 0091-6749 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
24
checked on 21-abr-2024
SCOPUSTM
Citations
70
checked on 17-abr-2024
WEB OF SCIENCETM
Citations
62
checked on 27-feb-2024
Page view(s)
358
checked on 24-abr-2024
Download(s)
102
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.